P3MC: A double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children

Trials

Volumn 11, Issue , 2010, Pages

  Silcocks, Paul ^a   Whitham, Diane ^a   Whitehouse, William P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PIZOTIFEN; PLACEBO; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SEROTONIN ANTAGONIST;

ADOLESCENT; ARM; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG PENETRATION; DRUG TOLERABILITY; EVENING DOSAGE; FOLLOW UP; FUTUROLOGY; HEART RATE; HUMAN; LENGTH OF STAY; MIGRAINE; MORNING DOSAGE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; SCHOOL; STRENGTH; TREATMENT RESPONSE; UNITED KINGDOM; ECONOMICS; HEALTH CARE COST; PLACEBO EFFECT; PRESCHOOL CHILD;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; MIGRAINE DISORDERS; OUTPATIENTS; PATIENT COMPLIANCE; PIZOTYLINE; PLACEBO EFFECT; PROPRANOLOL; SEROTONIN ANTAGONISTS;

EID: 77954574005     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-71     Document Type: Article

References (20)

1. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders. Cephalalgia 2004, 24(Suppl 1):1-160. 2, Headache Classification Subcommittee of the International Headache Society.
2. Victor S, Ryan SW. Drugs for preventing migraine headaches in children. The Cochrane Database of Systematic Reviews 2003, (4):CD002761. DOI: 10.1002/14651858.CD002761..
3. Van der Kuy P-HM, Lohman JJHM. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002, 22:265-270. 10.1046/j.1468-2982.2002.00363.x, 12100088.
4. Bille B. 40-year follow-up of school children with migraine. Cephalalgia 1997, 17:488-491. 10.1046/j.1468-2982.1997.1704488.x, 9209767.
5. Rabkin R, Stables DP, Levin NW, Suzman M. The prophylactic value of propranolol in angina pectoris. American Journal of Cardiology 1966, 18:370-83. 10.1016/0002-9149(66)90056-7, 4958813.
6. Royal College of Paediatrics & Child Health, Neonatal & Paediatric Pharmacy Group Medicines for Children. London 2003, 2, Royal College of Paediatrics & Child Health, Neonatal & Paediatric Pharmacy Group.
7. Paediatric Formulary Committee Royal College of Paediatrics & Child Health, British Medical Association, Royal Pharmaceutical Society of Great Britain British National Formulary for Children 2005, London: BMJ Publishing Group Ltd, Paediatric Formulary Committee Royal College of Paediatrics & Child Health, British Medical Association, Royal Pharmaceutical Society of Great Britain.
8. Machin D, Campbell M, Fayers P, Pinol A. Sample size tables for clinical studies 1997, Oxford: Blackwell Science, 2.
9. BPNA Governance & Audit Group. Headache Diary. 2003, , http://www.bpna.org.uk/audit/Headache%20diary.PDF
10. Headache Classification Subcommittee of the International Headache Society The International Classification of Headache Disorders (2nd ed). Cephalalgia 2004, 24(Suppl 1):150-151. Headache Classification Subcommittee of the International Headache Society.
11. Hershey AD, Powers SW, Vockell A-LB, LeCates S, Kabbouche M. Development of a patient-based grading scale for PedMIDAS. Neurology 2001, 57:2034-2039.
12. Collier J, MacKinlay D. Developing a generic child quality of life questionnaire. British Psychological Society Health Psychology Update 1997, 28:12-16.
13. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943.
14. Hennessy S, Kind P. The adaptation of EQ-5D for use with children 2002, Colindale: MRC funded study for Public Health Laboratory.
15. Kind P. The EuroQoL instrument: An index of health-related quality of life. Quality of life and pharmacoeconomics in clinical trials 1996, 191-201. Philadelphia: Lippincott-Raven, Spilker B, 2.
16. National Statistics Socio-economic Classification (NS-SEC). , http://www.statistics.gov.uk/methods_quality/ns_sec/nssec_self_coded_method.asp
17. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. British Journal of Radiology 1971, 44:793-797. 10.1259/0007-1285-44-526-793, 4940475.
18. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. I. Introduction and Design. British Jounal of Cancer 1976, 34:585-61221.
19. MedDRA. , http://www.meddramsso.com/mssoweb/index.htm
20. Royston P. Multiple imputation of missing values: Update of ice. Stata Journal 2005, 5:527-536.